Wellysis Corp.

Wellysis Corp. is a digital health company specializing in wearable ECG monitoring and remote cardiac surveillance solutions. The company manufactures and distributes the S-Patch line, a patch-type ECG device powered by Samsung Smart Health Processor, designed as a replacement for traditional Holter monitors. The S-Patch ecosystem comprises four integrated components: (1) S-Patch Wear—a lightweight, wearable biosignal collection device available in standard (Ex) and extended (ExL) formats; (2) S-Patch App—a mobile application for real-time data monitoring compatible with both iOS and Android; (3) S-Patch Physician Web—a cloud-based reading and analysis platform with comprehensive ECG report generation; and (4) S-Patch AI—algorithmic decision-support functionality integrated across the platform. The company also offers SDK and API interoperability solutions for healthcare system integration. Wellysis received FDA 510(k) clearance in September 2023 and has established partnerships with major healthcare institutions, including Samsung Electronics, Kangbuk Samsung Hospital, and clinical organizations in the US and India. The platform targets hospitals, clinics, cardiac monitoring centers, and telehealth service providers. Recent strategic partnerships include collaborations with Medicalgorithmics S.A. and HeartcoR Solutions, expanding distribution in clinical trial and remote monitoring markets. The company is headquartered in South Korea with active US market presence.